The Beneficial Effect of Oral Sodium Bicarbonate in Peritoneal Dialysis Patients — How Long Does It Last After Stopping Treatment?
Article Outline
Background
Acidosis is a major feature of progressive malnutrition in dialysis patients. Our previous study showed that in peritoneal dialysis (PD) patients with mild acidosis, oral sodium bicarbonate improved nutritional status and reduced hospitalization. However, the required duration of bicarbonate treatment remains unknown. Methods: Patients who participated in our previously reported randomized, controlled study of sodium bicarbonate therapy (J Am Soc Nephrol 2003;14:2119-26) were followed for another 12 months after treatment was stopped. We compared the two groups (i.e. sodium bicarbonate therapy vs placebo) with regard to nutritional status, including subjective global assessment (SGA) score and normalized protein nitrogen appearance (NPNA), and hospitalization and mortality.
Results
In the treatment group, the overall SGA score tended to fall to the pretreatment level 12 months after bicarbonate therapy was stopped (5.15 ± 1.04 to 4.68 ± 0.99, p = 0.08). After 12 months, there was no difference in overall SGA score between the treatment and placebo groups (4.68 ± 0.99 vs 4.58 ± 1.10, p = 0.5). NPNA of the treatment group remained marginally higher than that of the placebo group (1.21 ± 0.49 vs 1.06 ± 0.49 g/kg/day, p = 0.21), although the difference was not statistically significant. There was no significant difference in the duration of hospitalization between groups after bicarbonate was stopped (12.3 ± 19.9 vs 16.9 ± 23.7 days/year; Kruskal-Wallis test, p = 0.31). The treatment group had a slightly higher actuarial patient survival (83.3% vs 76.7%; log-rank test, p = 0.22), but the difference was not statistically significant.
Conclusion
The therapeutic benefits of oral sodium bicarbonate disappeared rapidly when treatment was stopped. Our results suggest that oral sodium bicarbonate is beneficial in PD patients with borderline dialysis adequacy and mild metabolic acidosis, and that these patients require long-term bicarbonate treatment.
Key words: continuous ambulatory peritoneal dialysis , metabolic acidosis , mortality , nutritional status , sodium bicarbonate
No full text is available. To read the body of this article, please view the PDF online.
References
- . Mechanisms of muscle wasting: the role of the ubiquitin-proteasome pathway . N Engl J Med . 1997;335:1897–1905
- Metabolic acidosis stimulates muscle protein degradation by activating the adenosine triphosphate-dependent pathway involving ubiquitin and proteasomes . J Clin Invest . 1994;93:2127–2133
- Rat muscle branched-chain ketoacid dehydrogenase activity and mRNAs increase with extracellular acidemia . Am J Physiol . 1995;268:C1395–C1400
- . Protein degradation and increased mRNAs encoding proteins of the ubiquitinproteasome proteolytic pathway in BC3H1 myocytes require interaction between glucocorticoids and acidification . Proc Natl Acad Sci USA . 1996;93:1967–1971
- . The acidosis of chronic renal failure activates muscle proteolysis in rats by augmenting transcription of genes encoding proteins of the ATP-dependent, ubiquitin-proteasome pathway . J Clin Invest . 1996;97:1447–1453
- . Correction of acidosis in humans with CRF decreases protein degradation and amino acid oxidation . Am J Physiol . 1993;265:E230–E235
- . Correction of acidosis in hemodialysis decreases whole-body protein degradation . J Am Soc Nephrol . 1997;8:632–637
- Correction of acidosis in CAPD decreases whole body protein degradation . Kidney Int . 1996;49:1396–1400
- . Nutrition in CAPD: serum bicarbonate and the ubiquitinproteasome system in muscle . Kidney Int . 2002;61:1286–1292
- . Oral sodium bicarbonate for the treatment of metabolic acidosis in peritoneal dialysis patients - a randomized placebo-control trial . J Am Soc Nephrol . 2003;14:2119–2126
- . Six years experience of CAPD at one centre: a survey of major findings . Perit Dial Int . 1988;8:31–41
- . Physiological transfer of acid base. . In: Legrain M editors. Continuous Ambulatory Peritoneal Dialysis. Proceedings of an International Symposium. . Amsterdam: Excerpta Medica; 1980;p. 194
- Cross-sectional assessment of weekly urea and creatinine clearances in patients on continuous ambulatory peritoneal dialysis . ASAIO J . 1992;38:M139–M142
- . Measurement of residual renal function in patients treated with continuous peritoneal dialysis . J Am Soc Nephrol . 1996;7:745–748
- . Interference of creatinine measurement in CAPD fluid was dependent on glucose and creatinine concentrations . Nephrol Dial Transplant . 1997;12:184–186
- II. NKF-K/DOQI Clinical practice guidelines for peritoneal dialysis adequacy: update 2000 . Am J Kidney Dis . 2001;37(Suppl 1):S65–136
- . Subjective global assessment of nutrition in dialysis patients . Nephrol Dial Transplant . 1993;8:1094–1098
- . Calculation of the protein equivalent of total nitrogen appearance from urea appearance. Which formulas should be used? . Perit Dial Int . 1998;18:467–473
- . Total body water volumes for adult males and females estimated from simple anthropometric measurements . Am J Clin Nutr . 1980;33:27–39
- . Urinary creatinine excretion and lean body mass . Am J Clin Nutr . 1976;29:1359–1366
- . Ammonium chloride-induced acidosis increases protein breakdown and amino acid oxidation in humans . Am J Physiol . 1992;263:E735–E739
- . Mechanisms for defects in muscle protein catabolism in rats with chronic uraemia . J Clin Invest . 1987;79:1099–1103
- . Glucocorticoids activate the ATP-ubiquitin-dependent proteolytic system in skeletal muscle during fasting . Am J Physiol . 1993;264:E668–E676
- The influence of bicarbonate supplementation on plasma levels of branched-chain amino acids in hemodialysis patients with metabolic acidosis . Nephrol Dial Transplant . 1997;12:2397–2401
- . Must metabolic acidosis be associated with malnutrition in hemodialysis patients? . Nephrol Dial Transplant . 2002;17:2006–2010
- . Increase of body mass during long-term bicarbonate hemodialysis . Kidney Int . 1987;22:S174–S177
- . The correction of acidosis does not increase dietary protein intake in chronic renal failure patients . Am J Kidney Dis . 1996;28:350–353
- Correction of metabolic acidosis increases serum albumin concentrations and decreases kinetically evaluated protein intake in haemodialysis patients: a prospective study . Nephrol Dial Transplant . 1998;13:1719–1722
- . Effect of the correction of metabolic acidosis on nutritional status in elderly patients with chronic renal failure . J Ren Nutr . 2002;12:224–228
- . Metabolic acidosis in maintenance dialysis patients: clinical considerations . Kidney Int . 2003;64(Suppl 88):S13–S25
- . High bicarbonate dialysate in haemodialysis patients: effects on acidosis and nutritional status . Nephrol Dial Transplant . 1997;12:2633–2637
- . Correction of metabolic acidosis and its effect on albumin in chronic hemodialysis patients . Am J Kidney Dis . 1998;31:35–40
- Role of an improvement in acid-base status and nutrition in CAPD patients . Kidney Int . 1997;52:1089–1095
- . Urea kinetic modeling exaggerates the relationship between nutrition and dialysis in CAPD patients. (The hazards of cross-sectional analysis.) . Perit Dial Int . 1995;15:105–109
PII: S1561-5413(09)60175-7
doi:10.1016/S1561-5413(09)60175-7
© 2005 The Hong Kong Society of Nephrology. Published by Elsevier Inc. All rights reserved.
